Publication: Incorporating the Gut Microbiome in the Risk Assessment of Xenobiotics and Identifying Beneficial Components for One Health.
dc.contributor.author | Ampatzoglou, Antonis | |
dc.contributor.author | Gruszecka-Kosowska, Agnieszka | |
dc.contributor.author | Torres-Sanchez, Alfonso | |
dc.contributor.author | Lopez-Moreno, Ana | |
dc.contributor.author | Cerk, Klara | |
dc.contributor.author | Ortiz, Pilar | |
dc.contributor.author | Monteoliva-Sanchez, Mercedes | |
dc.contributor.author | Aguilera, Margarita | |
dc.contributor.funder | EU-FORA Program (Cycle 2020/2021 and 2021/2022) | |
dc.contributor.funder | FEDER-Microbiota Infrastructure: IE19_198 UGR, OBEMIRISK EFSA-Partnering | |
dc.contributor.funder | Europa Investigación EIN2019-103082. | |
dc.date.accessioned | 2023-05-03T13:41:50Z | |
dc.date.available | 2023-05-03T13:41:50Z | |
dc.date.issued | 2022-03-031 | |
dc.description.abstract | Three areas of relevance to the gut microbiome in the context of One Health were explored; the incorporation of the microbiome in food safety risk assessment of xenobiotics; the identification and application of beneficial microbial components to various areas under One Health, and; specifically, in the context of antimicrobial resistance. Although challenging, focusing on the microbiota resilience, function and active components is critical for advancing the incorporation of microbiome data in the risk assessment of xenobiotics. Moreover, the human microbiota may be a promising source of beneficial components, with the potential to metabolize xenobiotics. These may have possible applications in several areas, e.g., in animals or plants for detoxification or in the environment for biodegradation. This approach would be of particular interest for antimicrobials, with the potential to ameliorate antimicrobial resistance development. Finally, the concept of resistance to xenobiotics in the context of the gut microbiome may deserve further investigation. | |
dc.description.version | Si | |
dc.identifier.citation | Ampatzoglou A, Gruszecka-Kosowska A, Torres-Sánchez A, López-Moreno A, Cerk K, Ortiz P, et al. Incorporating the Gut Microbiome in the Risk Assessment of Xenobiotics and Identifying Beneficial Components for One Health. Front Microbiol. 2022 May 4;13:872583. | |
dc.identifier.doi | 10.3389/fmicb.2022.872583 | |
dc.identifier.issn | 1664-302X | |
dc.identifier.pmc | PMC9116292 | |
dc.identifier.pmid | 35602014 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116292/pdf | |
dc.identifier.unpaywallURL | https://www.frontiersin.org/articles/10.3389/fmicb.2022.872583/pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/20623 | |
dc.journal.title | Frontiers in microbiology | |
dc.journal.titleabbreviation | Front Microbiol | |
dc.language.iso | en | |
dc.organization | Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA) | |
dc.page.number | 7 | |
dc.provenance | Realizada la curación de contenido 20/08/2024 | |
dc.publisher | Frontiers Research Foundation | |
dc.pubmedtype | Journal Article | |
dc.relation.projectID | GP/EFSA/ENCO/2018/03-GA04 | |
dc.relation.publisherversion | https://doi.org/10.3389/fmicb.2022.872583 | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | antimicrobial resistance | |
dc.subject | gut microbiome | |
dc.subject | microbiota disrupting chemicals | |
dc.subject | next-generation probiotics | |
dc.subject | next-generation risk assessment | |
dc.subject | one health | |
dc.subject | xenobiotics | |
dc.subject.decs | Animales | |
dc.subject.decs | Antibacterianos | |
dc.subject.decs | Antiinfecciosos | |
dc.subject.decs | Farmacorresistencia bacteriana | |
dc.subject.decs | Humanos | |
dc.subject.decs | Microbioma gastrointestinal | |
dc.subject.decs | Microbiota | |
dc.subject.decs | Resiliencia psicológica | |
dc.subject.decs | Salud única | |
dc.subject.decs | Xenobióticos | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Gastrointestinal Microbiome | |
dc.subject.mesh | Anti-Bacterial Agents | |
dc.subject.mesh | Xenobiotics | |
dc.subject.mesh | One Health | |
dc.subject.mesh | Resilience, Psychological | |
dc.subject.mesh | Drug Resistance, Bacterial | |
dc.subject.mesh | Microbiota | |
dc.subject.mesh | Anti-Infective Agents | |
dc.title | Incorporating the Gut Microbiome in the Risk Assessment of Xenobiotics and Identifying Beneficial Components for One Health. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 13 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1